Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
NCT05711758 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2026-03-02
Summary
Gastric myotomy has been performed for several years as a means of addressing chronic stenosis after sleeve gastrectomy and treating gastroparesis. The Pylorus Sparing Antral Myotomy (PSAM) technique has the opposite effect by leaving the pylorus intact and extending the myotomy proximally to the distal gastric body. PSAM was initially combined with ESG and shown to delay gastric emptying and provide greater weight loss without impacting tolerability (GCSI score) or the safety profile of the procedure (2 DDW GEM abstracts). PSAM has not been evaluated alone, without concomitant ESG. Since delayed gastric emptying alone is known to promote weight loss, it is thought that PSAM alone (without ESG) may provide similar efficacy, while reducing procedure time and adverse events. There have been no clinical studies that investigate the efficacy of PSAM independent of ESG. This pilot study aims to address this lack of information by evaluating the safety, tolerability, and short-term efficacy of PSAM, in addition to exploring its impact on gastric physiology. This will also provide data that may be used in designing a larger clinical trial.
Conditions
- Obesity
- Obesity, Morbid
- Obesity, Primary
- Metabolic Disease
- Delayed Gastric Emptying Following Procedure
Interventions
- PROCEDURE
-
PSAM Treatment Patients
PSAM is a pylorus-sparing antral myotomy performed under general anesthesia. Endoscopic myotomy is then performed applying the principles of submucosal endoscopy and techniques used during gastric per-oral endoscopic myotomy (G-POEM). A submucosal bleb is created proximal to the pylorus. A longitudinal mucosal incision is made with an endoscopic knife. The endoscope is then introduced into the submucosal space, and the knife is used to dissect the submucosal fibers. Antral myotomy is performed starting proximal to the pyloric ring extending to the mucosal access site. The myotomy entails cutting of the inner circular and oblique muscle bundles or may be full thickness at the discretion of the endoscopist. The mucosal entry is then closed using endoscopic suturing or clips.
Sponsors & Collaborators
-
Christopher C. Thompson, MD, MSc
lead OTHER
Principal Investigators
-
Christopher C. Thompson, MD, MSc · Brigham and Women's Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-22
- Primary Completion
- 2026-12-31
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Feasibility of Laparoscopic Sleeve Gastrectomy in Day Case Surgery
NCT01513005 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea and Vomiting in the Bariatric Surgery Population
NCT06585540 ·Status: RECRUITING ·Phase: PHASE3
-
Sonographic Evaluation of Visceral Fat After Bariatric Surgery
NCT01285791 ·Status: COMPLETED
-
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy
NCT03526263 ·Status: COMPLETED ·Phase: NA
-
Laparoscopic Bariatric Surgery: Impact of Deep Neuromuscular Block on Surgical Conditions
NCT02118844 ·Status: UNKNOWN ·Phase: PHASE4
-
Botulinum Toxin Pyloroplasty to Reduce Postoperative Nausea and Vomiting After Sleeve Gastrectomy
NCT03701919 ·Status: COMPLETED ·Phase: PHASE4
-
Gastrointestinal Physiological Conditions in Obesity and After Bariatric Surgery
NCT03783052 ·Status: COMPLETED ·Phase: NA
-
Laparoscopic Gastric Plication Operation for Patients With Severe or Morbid Obesity
NCT01207609 ·Status: COMPLETED ·Phase: NA
-
Impact of the Residual Gastric Volume in Laparoscopic Sleeve Gastrectomy's Failure
NCT01539967 ·Status: COMPLETED ·Phase: NA
-
Mechanism of Weight Loss After Endoscopic and Laparoscopic Sleeve Procedures
NCT04006002 ·Status: TERMINATED
-
Effect of Pulmonary Recruitment Maneuver (PRM) on Pain and Nausea After Laparoscopic Bariatric Surgery
NCT03026530 ·Status: COMPLETED ·Phase: NA
-
Mucosal Impedance Sleeve Gastrectomy
NCT04166461 ·Status: RECRUITING
-
Impact of Size of Gastric Sleeve on the Weight Loss. Correlation With Gastric Function and Endocrine-metabolic Changes.
NCT02144545 ·Status: UNKNOWN ·Phase: NA
-
Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery
NCT05016180 ·Status: UNKNOWN ·Phase: PHASE2
-
Omentopexy After Sleeve Gastrectomy in Children and Adolescences.
NCT06811623 ·Status: COMPLETED ·Phase: NA
-
Laparoscopic Sleeve Gastrectomy With and Without Omentectomy
NCT00434525 ·Status: COMPLETED ·Phase: PHASE3
-
Autonomic Neural Blockade in Bariatric Surgery
NCT07104825 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Gastric Bypass on the Absorption of Metformin
NCT01013051 ·Status: COMPLETED
-
The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting
NCT05772676 ·Status: UNKNOWN ·Phase: PHASE4
-
Physiological Responses to Laparoscopic Sleeve Gastrectomy: Focusing on Ghrelin
NCT04055025 ·Status: COMPLETED ·Phase: NA
-
Surgical Conditions During Laparoscopic Bariatric Surgery
NCT02703909 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Simvastatin Post Laparoscopic Sleeve Gastrectomy (LSG)
NCT03571802 ·Status: UNKNOWN ·Phase: PHASE4
-
Ghrelin Changes After Roux-en-Y Gastric Bypass
NCT00765596 ·Status: COMPLETED
-
The Effect of Anesthetic Methods on Gastrointestinal Motility
NCT05951686 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Results of Endoscopic Gastroplasty Using Overstitch in Patients With Class I and II Obesity
NCT03493620 ·Status: COMPLETED ·Phase: NA